Article, 2024

Allergen Immunotherapy: The Evidence Supporting the Efficacy and Safety of Subcutaneous Immunotherapy and Sublingual Forms of Immunotherapy for Allergic Rhinitis/Conjunctivitis and Asthma

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, ISSN 2213-2198, Volume 12, 6, Pages 415-427, 10.1016/j.jaip.2024.04.034

Contributors

Creticos, P. S. (Corresponding author) [1] [2] Gunaydin, Fatma E. [3] Nolte, Hendrik 0000-0003-2138-8510 [4] [5] Damask, Cecilia [6] Durham, Stephen R. 0000-0003-1299-0569 [7] [8]

Affiliations

  1. [1] Cret Res Grp, Crownsville, MD USA
  2. [NORA names: United States; America, North; OECD];
  3. [2] Johns Hopkins Div Allergy & Clin Immunol, Baltimore, MD 21224 USA
  4. [NORA names: United States; America, North; OECD];
  5. [3] Ordu Univ Educ & Res Hosp, Dept Immunol & Allergy, TR-52200 Ordu, Turkiye
  6. [4] ALK, Bedminster, NJ USA
  7. [NORA names: United States; America, North; OECD];
  8. [5] ALK, Horsholm, Denmark
  9. [NORA names: ALK-Abello; Private Research; Denmark; Europe, EU; Nordic; OECD];

Abstract

Abstract not displayed. As this article is not marked as Open Access, it is unclear if we are allowed to show the abstract. Please use the link in the sidebar to view the data provider version of the article including abstract.

Keywords

AIT, SCIT, SLIT-drops, SLIT-tablets, adherence, allergic asthma, allergic rhinitis

Data Provider: Clarivate